Tissue expression of 165-aa vascular permeability factor after spinal cord injury is not influenced by dexamethasone administration in rats

Neuroscience Letters

Volumn 365, Issue 3, 2004, Pages 214-217

  Vaquero, Jesús ^a   Zurita, Mercedes ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Angiogenesis factors; Dexamethasone; Spinal cord injury; Vascular permeability factor

Indexed keywords

DEXAMETHASONE; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; FEMALE; IMMUNOHISTOCHEMISTRY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY; WESTERN BLOTTING;

ANIMALS; DEXAMETHASONE; FEMALE; IMMUNOHISTOCHEMISTRY; NEUROPROTECTIVE AGENTS; PARAPLEGIA; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SPINAL CORD INJURIES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 3042705816     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2004.04.082     Document Type: Article

References (25)

1. J.W.F. Beks, H. Doorenbos, G.J.M. Walstra, Clinical experiences with steroids in neurosurgical patients, in: H.J. Reulen, K. Schürmann (Eds.), Steroids and Brain Edema, Springer-Verlag, Berlin, Heidelberg, New York, 1972, pp. 233-238.
2. Connolly D.T., Heuvelman D.M., Nelson P., Olander J.V., Eppley B.L., Delfino J.J., Siegel N.R., Leimgruber R.M., Feder J. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J. Clin. Invest. 84:1989;1470-1478
3. Dvorak H.F., Detmar M., Claffey K.P., Nagy J.A., Van De Water L., Senger D.R. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation. Int. Arch. Allergy Immunol. 107:1995;233-235
4. Faden A.I., Jacobs T.P., Patrick D.H., Smith M.T. Megadose corticosteriod therapy following experimental traumatic spinal cord injury. J. Neurosurg. 60:1984;712-717
5. Faden A.I., Jacobs T.P., Smith M.T., Holaday J.W. Comparison of thyrotropin-releasing hormone (TRH), naloxone and dexamethasone treatment in experimental spinal injuries. Neurology. 33:1983;673-678
6. Galicich J.H., French L.A. Use of dexamethasone in treatment of cerebral edema associated with brain tumors. Lancet. 81:1961;46-53
7. Goldman C.K., Bharara S., Palmer C.A., Vitek J., Tsai J., Weiss H.L., Gillespie G.Y. Brain edema in meningiomas is associated with increased vascular endothelial growth factor expression. Neurosurgery. 40:1997;1269-1277
8. Hall E.D. The neuroprotective pharmacology of methylprednisolone. J. Neurosurg. 76:1992;13-22
9. Hoerlin B.F., Redding R.W., Hoff E.J., McGuire J.A. Evaluation of dexamethasone, DMSO, mannitol and solcoseryl in acute spinal cord trauma. J. Am. Anim. Hosp. Assoc. 19:1983;216-226
10. Kalaria R.N., Cohen D.L., Al-Mudallal A.S., Lust W.D., Premkumar D.R.D. VEGF/PVF expression in ischemic brain injury and human degenerative disorders. J. Cereb. Blood Flow Metab. 15:1995;S599
11. Kiwerski J.E. Application of dexamethasone in the treatment of acute spinal cord injury. Injury. 24:1993;457-460
12. Nag S., Takahashi J.L., Kilty D.W. Role of vascular endothelial growth factor in blood-brain barrier breakdown and angiogenesis in brain trauma. J. Neuropathol. Exp. Neurol. 56:1997;912-921
13. Ogata T., Nakamura Y., Tsuji K., Shibata T., Kataoka K. Steroid hormones protect spinal cord neurons from glutamate toxicity. Neuroscience. 55:1993;445-449
14. Osterholm J.L., Mathews G.H. Altered metabolism following experimental spinal cord injury. Part I. Protection against traumatic spinal cord hemorrhagic necrosis by norepinephrine synthesis blockade with alpha-methyltyrosine. J. Neurosurg. 36:1972;386-394
15. Osterholm J.L., Mathews G.J. Altered metabolism following experimental spinal cord injury. Part II. Protection against traumatic spinal cord hemorrhagic necrosis by norepinephrine synthesis blockade with alpha-methyltyrosine. J. Neurosurg. 36:1972;395-401
16. Poltorak Z., Cohen T., Neufeld G. The VEGF splice variants: properties, receptors, and usage for the treatment of ischemic diseases. Herz. 25:2000;126-129
17. Provias J., Claffey K., Del Aguila L., Lau N., Feldkamp M., Guha A. Meningiomas: role of vascular endothelial growth factor/vascular permeability factor in angiogenesis and peritumoral edema. Neurosurgery. 40:1997;1016-1026
18. Robinson C.J., Stringer S.E. The splice variants of vascular endothelial growth factor (VEGF) and their receptors. J. Cell Sci. 114:2001;853-865
19. Shweiki D., Itin A., Soffer D., Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature. 359:1992;843-845
20. Strugar J.G., Rothbart D., Harrington W., Criscuolo G.R. Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J. Neurosurg. 81:1994;560-566
21. Tator C.H., Deecke L. Value of normothermic perfusion, hypothermic perfusion, and durotomy in the treatment of experimental acute spinal cord trauma. J. Neurosurg. 39:1973;52-64
22. Vaquero J., Zurita M., Oya S. Expression of vascular permeability factor in reactive astrocytes surrounding malignant gliomas. Neuropathol. Appl. Neurol. 28:2002;339-341
23. Vaquero J., Zurita M., Oya S., Coca S. Vascular endothelial growth/permeability factor in spinal cord injury. J. Neurosurg. (Spine 2). 90:1999;220-223
24. M. Zurita, S. Oya, C. Morales, J.G. López, C. Cevallos, J. Vaquero, Effects of dexamethasone administration on the posttraumatic demyelination in an experimental model of spinal cord contusion, in: Polytraumatized, Mapfre Medicine ed., Madrid, 1994, pp. 343-349 (in Spanish).
25. Zurita M., Vaquero J., Oya S., Morales C. Effects of dexamethasone on apoptosis-related cell death after spinal cord injury. J. Neurosurg. (Spine 1). 96:2002;83-89